These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 20438521)
1. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia. Moriarty P; Sosland R; Gibson C; Belmont J Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521 [TBL] [Abstract][Full Text] [Related]
2. Apheresis technologies for prevention and regression of atherosclerosis: clinical results. Bambauer R; Schneidewind JM; Latza R ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615 [TBL] [Abstract][Full Text] [Related]
3. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis. Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056 [TBL] [Abstract][Full Text] [Related]
4. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group. Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308 [TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy. Gordon BR; Saal SD J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816 [TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial. Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134 [TBL] [Abstract][Full Text] [Related]
7. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis. Sosland RP; Gollub SB; Wilson DB; Moriarty PM Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545 [TBL] [Abstract][Full Text] [Related]
8. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia. Otto C; Berster J; Otto B; Parhofer KG J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245 [TBL] [Abstract][Full Text] [Related]
9. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia. Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288 [TBL] [Abstract][Full Text] [Related]
10. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis. McGowan MP J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325 [TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients. Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534 [TBL] [Abstract][Full Text] [Related]
12. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia]. Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990 [TBL] [Abstract][Full Text] [Related]
13. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy]. Seidel D Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia. Gülle S; Bak M; Serdaroglu E; Can D; Karabay O Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523 [TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells. Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493 [TBL] [Abstract][Full Text] [Related]
16. Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol. Opole IO; Belmont JM; Kumar A; Moriarty PM Am J Cardiol; 2007 Nov; 100(9):1416-8. PubMed ID: 17950800 [TBL] [Abstract][Full Text] [Related]
17. One year experience with a low density lipoprotein apheresis system. Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228 [TBL] [Abstract][Full Text] [Related]
18. [H.E.L.P. apheresis and oxidative stress]. Pulawski E; Mellwig KP; Horstkotte D Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia. Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957 [TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years. Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]